PRF Technologies is a diversified innovation company advancing specialty pharmaceutical therapies and AI-driven energy analytics.
Our pharmaceutical programs focus on reformulation and sustained-release drug-delivery technologies designed to improve patient outcomes while reducing reliance on opioids and complex dosing regimens.
Our advanced AI solutions enable solar asset owners and operators to optimize energy performance.
Products
PRF-110 is an oil-based, viscous clear solution that is deposited directly into the surgical wound bed to provide localized and extended post-operative analgesia.
OcuRingTD is a polymer-based bio-erodible platform for an extended drug release in the ophthalmology surgeries arena.
DeepSolar platform offers advanced AI solutions that enable solar asset owners and operators to monitor, forecast, and optimize energy performance across the full asset lifecycle.